Bill Text — Mar 20, 2013
This bill’s text is now available.
May 26, 2011
112th Congress, 2011–2013
This bill was introduced on May 26, 2011, in a previous session of Congress, but was not enacted.
Senator from Vermont
Read Text »
Last Updated: May 26, 2011
Length: 25 pages
A bill to provide incentives for investment in research and development for new medicines, to enhance access to new medicines, and for other purposes.
5/26/2011--Introduced.Medical Innovation Prize Fund Act - Denies any person the exclusive right to manufacture, distribute, sell, or use in interstate commerce a drug, a biological product, or a drug or ... Read more >
The bill’s title was written by its sponsor.
This is the first step in the legislative process.
Reintroduced Bill — Introduced
This activity took place on a related bill, S. 627 (113th).
This is a Senate bill in the United States Congress (indicated by the “S.” in “S. 1137”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The committee chair determines whether a bill will move past the committee stage.
There have been no roll call votes related to this bill.
Click a format for a citation suggestion:
Civic Impulse. (2015). S. 1137 — 112th Congress: Medical Innovation Prize Fund Act. Retrieved from https://www.govtrack.us/congress/bills/112/s1137
“S. 1137 — 112th Congress: Medical Innovation Prize Fund Act.” www.GovTrack.us. 2011. November 26, 2015 <https://www.govtrack.us/congress/bills/112/s1137>
|title=S. 1137 (112th)
|accessdate=November 26, 2015
|author=112th Congress (2011)
|date=May 26, 2011
|quote=Medical Innovation Prize Fund Act